-
1
The study evaluates miECCO2R using CRRT, highlighting its potential to reduce ventilatory intensity and achieve near-normocapnia in hypercapnic respiratory failure patients.
-
2
Clinically meaningful reductions in PaCO2 and normalization of pH were observed with low blood flow rates of 100-400 mL/min during the CRRT-miECCO2R approach.
-
3
Peristaltic pumps, used in CRRT, have a long history of safe application in extracorporeal therapies, with complications more often related to vascular access and anticoagulation.
-
4
Current CRRT platforms include operational limits to maintain circuit integrity, prompting circuit replacement after reaching maximum filter runtime or processed blood volume.
-
5
Future developments in CRRT may enhance anticoagulation protocols and integrated functionalities, supporting multiorgan management while maintaining safety in higher blood flow conditions.
